Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

222 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and tolerability of tropisetron in primary fibromyalgia--a highly selective and competitive 5-HT3 receptor antagonist. German Fibromyalgia Study Group.
Färber L, Stratz T, Brückle W, Späth M, Pongratz D, Lautenschläger J, Kötter I, Zöller B, Peter HH, Neeck G, Alten R, Müller W. Färber L, et al. Among authors: pongratz d. Scand J Rheumatol Suppl. 2000;113:49-54. doi: 10.1080/030097400446643. Scand J Rheumatol Suppl. 2000. PMID: 11028832 Clinical Trial.
The challenge of fibromyalgia: new approaches.
Müller W, Pongratz D, Bärlin E, Eich W, Färber L, Haus U, Lautenschläger J, Mense S, Neeck G, Offenbächer M, Späth M, Stratz T, Tolk J, Welzel D, Wiech K, Wohlgemuth M. Müller W, et al. Among authors: pongratz d. Scand J Rheumatol Suppl. 2000;113:86. Scand J Rheumatol Suppl. 2000. PMID: 11028839 No abstract available.
[Fibromyalgia].
Pongratz D, Späth M. Pongratz D, et al. Fortschr Neurol Psychiatr. 2001 Apr;69(4):189-93. doi: 10.1055/s-2001-12677. Fortschr Neurol Psychiatr. 2001. PMID: 11386124 Review. German.
Short-term treatment of primary fibromyalgia with the 5-HT3-receptor antagonist tropisetron. Results of a randomized, double-blind, placebo-controlled multicenter trial in 418 patients.
Färber L, Stratz TH, Brückle W, Späth M, Pongratz D, Lautenschläger J, Kötter I, Zöller B, Peter HH, Neeck G, Welzel D, Müller W; German Fibromyalgia Study Group. Färber L, et al. Among authors: pongratz d. Int J Clin Pharmacol Res. 2001;21(1):1-13. Int J Clin Pharmacol Res. 2001. PMID: 11708570 Clinical Trial.
Morphologic aspects of fibromyalgia.
Pongratz DE, Späth M. Pongratz DE, et al. Z Rheumatol. 1998;57 Suppl 2:47-51. doi: 10.1007/s003930050234. Z Rheumatol. 1998. PMID: 10025082 Review.
The T102C polymorphism of the 5-HT2A-receptor gene in fibromyalgia.
Bondy B, Spaeth M, Offenbaecher M, Glatzeder K, Stratz T, Schwarz M, de Jonge S, Krüger M, Engel RR, Färber L, Pongratz DE, Ackenheil M. Bondy B, et al. Among authors: pongratz de. Neurobiol Dis. 1999 Oct;6(5):433-9. doi: 10.1006/nbdi.1999.0262. Neurobiol Dis. 1999. PMID: 10527809
222 results